BRAFTOVI (encorafenib) capsules
Product Brand Name: BRAFTOVI. API Name: encorafenib. BRAFTOVI (encorafenib) capsules is a prescription medicine used: in combination with a prescription medicine called MEKTOVI (binimetinib) to treat adults with a type of skin cancer called melanoma
Braftovi is available as capsules (50 mg and 75 mg). For melanoma, patients normally take 450 mg (six 75-mg capsules) once a day and for colorectal cancer the recommended dose is 300 mg (four 75-mg capsules). The dose may be reduced or treatment stopped temporarily if patients experience troublesome side effects. The dose of the other medicine, binimetinib or cetuximab, may also be reduced but if the other medicine is stopped Braftovi must be stopped too.
Generic name: encorafenib
Brand name: Braftovi
Dosage form: oral capsule (75 mg)
Drug class: Multikinase inhibitors
For Best Price: To know the best price of the product available with Lucknow Speciality Pharma call at Contact No. 9760014849, 9555306364, 9794360370, 9140551027 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
About Us
Lucknow Speciality Pharma is a registered Pharmaceutica Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Get Access To BRAFTOVI (encorafenib) capsules
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Nepal
Braftovi is available as capsules (50 mg and 75 mg). For melanoma, patients normally take 450 mg (six 75-mg capsules) once a day and for colorectal cancer the recommended dose is 300 mg (four 75-mg capsules). The dose may be reduced or treatment stopped temporarily if patients experience troublesome side effects. The dose of the other medicine, binimetinib or cetuximab, may also be reduced but if the other medicine is stopped Braftovi must be stopped too.
encorafenib is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “BRAFTOVI (encorafenib) capsules“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Medicines Delivered
We have supplied to following cities in India-
Lucknow Speciality Pharma has delivered “BRAFTOVI (encorafenib) capsules” in Kanpur, Lucknow, Ghaziabad, Agra, Meerut, Varanasi, Prayagraj, Bareilly, Aligarh, Moradabad, Saharanpur, Gorakhpur, Noida, Firozabad, Jhansi, Muzaffarnagar, Mathura-Vrindavan, Ayodhya, Rampur, Shahjahanpur, Farrukhabad-Fatehgarh, Budaun, Maunath, Hapur, Etawah, Mirzapur-Vindhyachal, Bulandshahr, Sambhal, Amroha, Hardoi, Fatehpur, Raebareli, Orai, Sitapur, Bahraich, Modinagar, Unnao, Jaunpur, Lakhimpur, Hathras, Banda, Pilibhit, Barabanki, Khurja, Gonda, Mainpuri, Lalitpur, Etah, Deoria, Badaun, Ghazipur, Sultanpur, Azamgarh, Bijnor, Sahaswan, Basti, Chandausi, Akbarpur, Ballia, Ambedkar Nagar, Greater Noida, Shikohabad, Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga, Siwan, Sasaram, Hajipur, Burdwan, Kolkata, Kharagpur, Asansol, Haldia, Siliguri, Howrah, Imphal, Guwahati and Agartala and Nepal.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
9555306364, 9794360370, 9140551027
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
